Logo 5363
Pill imprint Logo 5363 has been identified as Benazepril and hydrochlorothiazide 20 mg / 25 mg.
Benazepril/hydrochlorothiazide is used in the treatment of high blood pressure and belongs to the drug class antihypertensive combinations. There is positive evidence of human fetal risk during pregnancy.
Benazepril/hydrochlorothiazide 20 mg / 25 mg is not subject to the Controlled Substances Act.
See also related documents.
Benazepril and hydrochlorothiazide Images
- Imprint:
-
Logo 5363
- Strength:
- 20 mg / 25 mg
- Color:
- Orange
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Inactive Ingredients:
- castor wax
silicon dioxide colloidal
crospovidone
hypromellose
lactose monohydrate
microcrystalline cellulose
polydextrose
polyethylene glycol
magnesium silicate
titanium dioxide
triacetin
FD&C Red No. 40 Aluminium Lake
FD&C Yellow No. 6 Aluminum Lake
- Drug Class:
- Antihypertensive combinations
- Pregnancy Category:
- D - Positive evidence of risk
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Teva Pharmaceuticals USA
- National Drug Code (NDC):
- 00172-5363
Advertisement
More Benazepril and Hydrochlorothiazide resources
- Benazepril/Hydrochlorothiazide (Wolters Kluwer)
- hydrochlorothiazide and benazepril (Cerner Multum)
- benazepril and hydrochlorothiazide (Micromedex) - Includes Dosage Information
- Benazepril and Hydrochlorothiazide (FDA)
- Benazepril Hydrochloride/Hydrochlorothiazide (Wolters Kluwer)
Search Again
